InvestorsHub Logo
Followers 2
Posts 333
Boards Moderated 0
Alias Born 07/19/2016

Re: None

Tuesday, 09/26/2017 7:44:20 PM

Tuesday, September 26, 2017 7:44:20 PM

Post# of 108192
What I find interesting in all this mess is that it's happening without anything happening with the science. Oh, sure, mediocre results in the single arm prostate, but no word at all on dual therapy.
I can't bring myself to believe there is insider information being fed to shorts, hedges, tutes, etc. Too much to risk, and orange is not a flattering color.
But, yeah, I can believe the system is rigged in other ways, including entities like Adage shorting their own shares. I was advised, actually, early in this investment, to buy out of the money put options as insurance against my investment. Advice I didn't take but now wish I had, for sure!

Thinking as I type, the timeline is interesting also, isn't it? Lombardo states they are focusing on shareholder value, something all shorts would take seriously. He states HER2 is up for sale or licensing, also a head turner for the shorts. Then without truly significant news on the science, a short attack. To me this stinks to high heaven, and in poker we have a saying: If the bet is intended to get you to call, fold. If the bet is intended to get you to fold, then hold on and call. And it sure looks like they want to get us to fold.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News